InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Inc. (TSX:IN;OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as an R&D pipeline of medications targeting diseases with high unmet medical needs, reported financial results for the three and nine months ended March 31, 2019.

What's the Real Link Between Pot Dispensaries and Crime Rates?

For years, opponents of marijuana legalization have voiced the same arguments whenever the subject of dispensaries comes up: having legal cannabis vendors, they say, promotes the spread of crime, brings property values down in the neighborhood and encourages teenage marijuana use.

Indus Holdings, Inc. Acquires W Vapes

Indus Holdings, Inc. (CSE: INDS), announced that it has signed a definitive agreement to acquire the assets of W The Brand ("W Vapes"), a multi-state manufacturer and distributor of cannabis concentrates, cartridges and disposable pens

California might triple number of marijuana shops across state

Escalating a feud with cities over marijuana, state lawmakers are pushing to require municipalities to lift bans on cannabis stores if voters there supported Proposition 64, the 2016 initiative that legalized sale of the drug for recreational use in California.